Skip to Content
Events

Ribbon Cutting Ceremony for $30M Facility Expansion

Ribbon cutting ceremony celebrating Bora Biologics’ $30 million expansion of its FDA registered manufacturing facility, increasing U.S. based biologics manufacturing capacity. The expansion adds state-of-the-art upstream and downstream GMP processing capabilities to support growing demand for 2,000 liter single use biologics manufacturing. The project included two to four 2,000 liter bioreactors, corresponding seed trains, and advanced downstream processing equipment, strengthening Bora Biologics’ ability to serve the local and global biotech community. The investment also supports continued job growth in San Diego’s life sciences sector.

Attendees

Bora Biologics executive leadership and team members
Special Guest: San Diego Mayor Todd Gloria
Invited biotechnology and community stakeholders

Time & Location

Thursday, January 22, 2026
1:00pm PT
Bora Biologics, Building 1
10421 Pacific Center Court
San Diego, CA 92121

RSVP







     

    Bora Biologics

    the logical choice

    Join the ranks of biopharma pioneers who trust us.
    Explore how we minimize risks and accelerate your success.

    Partner with us

    Client-Centric

    100% commitment to supporting your success

    We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

    Experience

    14 years developing & manufacturing biologics

    We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

    Expertise

    125 seasoned scientists & regulatory professionals

    Our team exudes deep knowledge and specialized skills. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

    Commercial-Ready

    US FDA registered GMP manufacturing facility

    We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

    Allied

    access to global CDMO resources

    Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.